24 Jul, 2018 RNAi Roundtable: Givosiran, in Development for the Treatment of Acute Hepatic Porphyrias
On July 24, 2018, we hosted an online RNAi Roundtable to review the progress with givosiran, an RNAi therapeutic in development for the treatment of acute hepatic porphyrias.
- Akin Akinc, Ph.D., General Manager, Givosiran
- Jae Kim, M.D., Vice President, Clinical Development
- Mary, patient living with acute intermittent porphyria